AFRO E: Cost effectiveness results for Maternal and Neonatal Health
This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2000.
KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
-
Summary
Summary of the methodologies used in the analysis -
Published research report
pdf, 167kb -
Excel Spreadsheet
xls, 92kb
Download this table in excel
| Interventions:Codes_and_Descriptions | Coverage | Cost per year (I$, millions) per one million_population [i.e. cost per capita] | % Program costs | % Patient costs | DALYs averted per year per one million_population | Average Cost per DALY averted | Incremental Cost per DALY averted |
| MNH-1: Community newborn care package | 50% | 0.09 | 21% | 79% | 10,752 | 8 | Dominated |
| MNH-2: Support for breastfeeding mothers | 50% | 0.09 | 19% | 81% | 9,118 | 10 | Dominated |
| MNH-3: Pre-eclampsia screening | 50% | 0.05 | 14% | 86% | 999 | 51 | Dominated |
| MNH-4: Tetanus toxoid | 50% | 0.06 | 13% | 87% | 4,666 | 12 | Dominated |
| MNH-5: Screening & treatment of asymptomatic bacteriuria | 50% | 0.03 | 22% | 78% | 518 | 63 | Dominated |
| MNH-6: Screening & treatment of syphilis | 50% | 0.03 | 21% | 79% | 428 | 80 | Dominated |
| MNH-7: Normal delivery by a skilled attendant | 50% | 0.16 | 7% | 93% | 4,208 | 37 | Dominated |
| MNH-8: Community-based case management for neonatal pneumonia | 50% | 0.00 | 62% | 38% | 2,214 | 1 | Dominated |
| MNH-9: Normal delivery by a skilled attendant + Tetanus Toxoid | 50% | 0.21 | 6% | 94% | 6,340 | 33 | Dominated |
| MNH-10: Management of maternal sepsis | 50% | 0.09 | 2% | 98% | 897 | 98 | Dominated |
| MNH-11: Management of severe neonatal asphyxia | 50% | 0.03 | 39% | 61% | 133 | 205 | Dominated |
| MNH-12: Management of serious newborn infections | 50% | 0.15 | 7% | 93% | 2,770 | 54 | Dominated |
| MNH-13: Management of very low birth weight babies | 50% | 0.04 | 30% | 70% | 997 | 36 | Dominated |
| MNH-14: Manangement of neonatal jaundice | 50% | 0.03 | 41% | 59% | 41 | 642 | Dominated |
| MNH-15: Tetanus toxoid + Pre-eclampsia screening | 50% | 0.08 | 10% | 90% | 5,673 | 15 | Dominated |
| MNH-16: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 50% | 0.09 | 13% | 87% | 6,196 | 14 | Dominated |
| MNH-17: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 50% | 0.09 | 15% | 85% | 6,613 | 14 | Dominated |
| MNH-18: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 50% | 0.23 | 7% | 93% | 7,717 | 30 | Dominated |
| MNH-19: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 50% | 0.21 | 7% | 93% | 8,033 | 27 | Dominated |
| MNH-20: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 50% | 0.37 | 4% | 96% | 8,244 | 45 | Dominated |
| MNH-21: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 50% | 0.27 | 6% | 94% | 7,849 | 34 | Dominated |
| MNH-22: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 50% | 0.26 | 8% | 92% | 6,663 | 38 | Dominated |
| MNH-23: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 50% | 0.33 | 5% | 95% | 7,859 | 42 | Dominated |
| MNH-24: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 50% | 0.25 | 5% | 95% | 7,426 | 34 | Dominated |
| MNH-25: Management of vLBW + Management of serious newborn infections | 50% | 0.18 | 8% | 92% | 3,774 | 47 | Dominated |
| MNH-26: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 50% | 0.20 | 7% | 93% | 3,909 | 50 | Dominated |
| MNH-27: ENC | 50% | 0.21 | 7% | 93% | 4,806 | 44 | Dominated |
| MNH-28: ENC + Management of maternal sepsis | 50% | 0.32 | 5% | 95% | 4,847 | 65 | Dominated |
| MNH-29: Community newborn care package + Community-based pneumonia | 50% | 0.10 | 29% | 71% | 13,030 | 8 | Dominated |
| MNH-30: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 50% | 0.25 | 9% | 91% | 8,211 | 30 | Dominated |
| MNH-31: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 50% | 0.28 | 8% | 92% | 9,016 | 31 | Dominated |
| MNH-32: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 50% | 0.31 | 7% | 93% | 8,720 | 36 | Dominated |
| MNH-33: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 50% | 0.39 | 6% | 94% | 10,526 | 37 | Dominated |
| MNH-34: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 50% | 0.36 | 6% | 94% | 9,007 | 40 | Dominated |
| MNH-35: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 50% | 0.44 | 6% | 94% | 10,704 | 41 | Dominated |
| MNH-36: Community newborn care package + Tetanus Toxoid | 50% | 0.15 | 18% | 82% | 15,418 | 10 | Dominated |
| MNH-37: Community-based pneumonia + Tetanus Toxoid | 50% | 0.06 | 15% | 85% | 6,880 | 9 | Dominated |
| MNH-38: Community-based pneumonia + ANC | 50% | 0.09 | 16% | 84% | 8,827 | 11 | Dominated |
| MNH-39: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 50% | 0.16 | 23% | 77% | 17,696 | 9 | Dominated |
| MNH-40: Support for breastfeeding mothers + Tetanus toxoid | 50% | 0.15 | 17% | 83% | 13,784 | 11 | Dominated |
| MNH-41: Community newborn care package + ANC | 50% | 0.18 | 18% | 82% | 17,365 | 10 | Dominated |
| MNH-42: Community newborn care package + ANC + Community-based pneumonia | 50% | 0.19 | 22% | 78% | 19,643 | 10 | Dominated |
| MNH-43: Community newborn care package + ANC + Community-based pneumonia + SMNC | 50% | 0.37 | 16% | 84% | 24,310 | 15 | Dominated |
| MNH-44: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 50% | 0.23 | 23% | 77% | 20,639 | 11 | Dominated |
| MNH-45: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 50% | 0.56 | 12% | 88% | 26,078 | 22 | Dominated |
| MNH-46: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 50% | 0.41 | 17% | 83% | 25,307 | 16 | Dominated |
| MNH-47: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 50% | 0.41 | 15% | 85% | 25,115 | 16 | Dominated |
| MNH-48: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 50% | 0.53 | 12% | 88% | 26,633 | 20 | Dominated |
| MNH-49: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.57 | 11% | 89% | 27,019 | 21 | Dominated |
| MNH-50: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 50% | 0.68 | 9% | 91% | 27,659 | 24 | Dominated |
| MNH-51: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 50% | 0.44 | 16% | 84% | 26,112 | 17 | Dominated |
| MNH-52: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 50% | 0.19 | 22% | 78% | 19,226 | 10 | Dominated |
| MNH-53: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 50% | 0.62 | 12% | 88% | 29,921 | 21 | Dominated |
| MNH-54: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.57 | 11% | 89% | 27,019 | 21 | Dominated |
| MNH-55: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 50% | 0.18 | 17% | 83% | 16,948 | 10 | Dominated |
| MNH-56: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.72 | 10% | 90% | 30,638 | 24 | Dominated |
| MNH-57: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 50% | 0.64 | 10% | 90% | 28,537 | 23 | Dominated |
| MNH-58: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 50% | 0.56 | 11% | 89% | 27,151 | 21 | Dominated |
| MNH-59: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 50% | 0.59 | 10% | 90% | 27,528 | 21 | Dominated |
| MNH-60: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 50% | 0.57 | 12% | 88% | 27,342 | 21 | Dominated |
| MNH-61: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 50% | 0.73 | 10% | 90% | 31,825 | 23 | Dominated |
| MNH-62: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 50% | 0.86 | 9% | 91% | 33,343 | 26 | Dominated |
| MNH-63: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.32 | 11% | 89% | 18,469 | 17 | Dominated |
| MNH-64: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.72 | 10% | 90% | 30,221 | 24 | Dominated |
| MNH-65: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 50% | 0.86 | 9% | 91% | 33,343 | 26 | Dominated |
| MNH-66: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 50% | 0.80 | 10% | 90% | 32,333 | 25 | Dominated |
| MNH-67: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 50% | 0.77 | 10% | 90% | 31,957 | 24 | Dominated |
| MNH-68: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 50% | 0.92 | 9% | 91% | 33,852 | 27 | Dominated |
| MNH-69: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 50% | 0.90 | 9% | 91% | 33,475 | 27 | Dominated |
| MNH-70: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 50% | 0.90 | 10% | 90% | 33,666 | 27 | Dominated |
| MNH-71: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 50% | 0.97 | 8% | 92% | 34,140 | 28 | Dominated |
| MNH-72: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 50% | 0.96 | 8% | 92% | 33,984 | 28 | Dominated |
| MNH-73: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 50% | 1.01 | 8% | 92% | 34,272 | 29 | Dominated |
| MNH-74: Community newborn care package + Tetanus Toxoid + SMNC | 50% | 0.32 | 12% | 88% | 20,161 | 16 | Dominated |
| MNH-75: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.33 | 14% | 86% | 20,747 | 16 | Dominated |
| MNH-76: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 50% | 0.34 | 15% | 85% | 22,440 | 15 | Dominated |
| MNH-77: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.35 | 11% | 89% | 19,999 | 17 | Dominated |
| MNH-78: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.36 | 14% | 86% | 22,277 | 16 | Dominated |
| MNH-79: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 50% | 0.46 | 8% | 92% | 21,903 | 21 | Dominated |
| MNH-80: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.47 | 10% | 90% | 24,181 | 20 | Dominated |
| MNH-81: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 50% | 0.47 | 9% | 91% | 23,595 | 20 | Dominated |
| MNH-82: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.47 | 10% | 90% | 24,181 | 20 | Dominated |
| MNH-83: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 50% | 0.48 | 11% | 89% | 25,873 | 18 | Dominated |
| MNH-84: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 50% | 0.40 | 13% | 87% | 24,774 | 16 | Dominated |
| MNH-85: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 50% | 0.56 | 10% | 90% | 26,678 | 21 | Dominated |
| MNH-86: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 50% | 0.46 | 12% | 88% | 25,283 | 18 | Dominated |
| MNH-87: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 50% | 0.44 | 12% | 88% | 24,906 | 18 | Dominated |
| MNH-88: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 50% | 0.50 | 11% | 89% | 25,415 | 20 | Dominated |
| MNH-89: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.83 | 8% | 92% | 32,125 | 26 | Dominated |
| MNH-90: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.83 | 9% | 91% | 32,541 | 26 | Dominated |
| MNH-91: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 50% | 0.88 | 8% | 92% | 32,829 | 27 | Dominated |
| MNH-92: Community newborn care package | 80% | 0.15 | 22% | 78% | 17,204 | 8 | Dominated |
| MNH-93: Support for breastfeeding mothers | 80% | 0.15 | 21% | 79% | 14,588 | 10 | Dominated |
| MNH-94: Pre-eclampsia screening | 80% | 0.10 | 16% | 84% | 1,598 | 65 | Dominated |
| MNH-95: Tetanus toxoid | 80% | 0.12 | 14% | 86% | 7,466 | 16 | Dominated |
| MNH-96: Screening & treatment of asymptomatic bacteriuria | 80% | 0.07 | 24% | 76% | 828 | 81 | Dominated |
| MNH-97: Screening & treatment of syphilis | 80% | 0.07 | 23% | 77% | 684 | 102 | Dominated |
| MNH-98: Normal delivery by a skilled attendant | 80% | 0.26 | 9% | 91% | 6,734 | 38 | Dominated |
| MNH-99: Community-based case management for neonatal pneumonia | 80% | 0.00 | 54% | 46% | 3,543 | 1 | Dominated |
| MNH-100: Normal delivery by a skilled attendant + Tetanus Toxoid | 80% | 0.36 | 7% | 93% | 10,145 | 36 | Dominated |
| MNH-101: Management of maternal sepsis | 80% | 0.15 | 2% | 98% | 1,436 | 107 | Dominated |
| MNH-102: Management of severe neonatal asphyxia | 80% | 0.05 | 45% | 55% | 213 | 251 | Dominated |
| MNH-103: Management of serious newborn infections | 80% | 0.27 | 9% | 91% | 4,432 | 60 | Dominated |
| MNH-104: Management of very low birth weight babies | 80% | 0.07 | 36% | 64% | 1,595 | 43 | Dominated |
| MNH-105: Manangement of neonatal jaundice | 80% | 0.05 | 47% | 53% | 65 | 793 | Dominated |
| MNH-106: Tetanus toxoid + Pre-eclampsia screening | 80% | 0.17 | 10% | 90% | 9,076 | 19 | Dominated |
| MNH-107: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 80% | 0.18 | 13% | 87% | 9,913 | 18 | Dominated |
| MNH-108: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 80% | 0.18 | 15% | 85% | 10,580 | 17 | Dominated |
| MNH-109: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 80% | 0.39 | 9% | 91% | 12,347 | 32 | Dominated |
| MNH-110: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 80% | 0.37 | 9% | 91% | 12,852 | 29 | Dominated |
| MNH-111: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 80% | 0.66 | 5% | 95% | 13,191 | 50 | Dominated |
| MNH-112: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 80% | 0.44 | 8% | 92% | 12,558 | 35 | Dominated |
| MNH-113: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 80% | 0.44 | 7% | 93% | 10,661 | 41 | Dominated |
| MNH-114: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 80% | 0.58 | 6% | 94% | 12,574 | 46 | Dominated |
| MNH-115: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 80% | 0.44 | 6% | 94% | 11,882 | 37 | Dominated |
| MNH-116: Management of vLBW + Management of serious newborn infections | 80% | 0.32 | 9% | 91% | 6,039 | 52 | Dominated |
| MNH-117: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 80% | 0.35 | 8% | 92% | 6,254 | 55 | Dominated |
| MNH-118: Emergency neonatal care | 80% | 0.38 | 8% | 92% | 7,689 | 49 | Dominated |
| MNH-119: ENC + Management of maternal sepsis | 80% | 0.55 | 6% | 94% | 7,755 | 71 | Dominated |
| MNH-120: Community newborn care package + Community-based pneumonia | 80% | 0.15 | 21% | 79% | 20,848 | 7 | Dominated |
| MNH-121: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 80% | 0.44 | 10% | 90% | 13,138 | 33 | Dominated |
| MNH-122: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 80% | 0.49 | 9% | 91% | 14,425 | 34 | Dominated |
| MNH-123: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 80% | 0.53 | 9% | 91% | 13,951 | 38 | Dominated |
| MNH-124: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 80% | 0.69 | 8% | 92% | 16,842 | 41 | Dominated |
| MNH-125: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 80% | 0.60 | 8% | 92% | 14,412 | 42 | Dominated |
| MNH-126: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 80% | 0.78 | 7% | 93% | 17,126 | 45 | Dominated |
| MNH-127: Community newborn care package + Tetanus Toxoid | 80% | 0.26 | 18% | 82% | 24,669 | 11 | Dominated |
| MNH-128: Community-based pneumonia + Tetanus Toxoid | 80% | 0.12 | 15% | 85% | 11,009 | 11 | Dominated |
| MNH-129: Community-based pneumonia + ANC | 80% | 0.19 | 16% | 84% | 14,123 | 13 | Dominated |
| MNH-130: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 80% | 0.26 | 18% | 82% | 28,314 | 9 | Dominated |
| MNH-131: Support for breastfeeding mothers + Tetanus toxoid | 80% | 0.27 | 18% | 82% | 22,054 | 12 | Dominated |
| MNH-132: Community newborn care package + ANC | 80% | 0.33 | 18% | 82% | 27,784 | 12 | Dominated |
| MNH-133: Community newborn care package + ANC + Community-based pneumonia | 80% | 0.33 | 18% | 82% | 31,429 | 11 | Dominated |
| MNH-134: Community newborn care package + ANC + Community-based pneumonia + SMNC | 80% | 0.62 | 15% | 85% | 38,896 | 16 | Dominated |
| MNH-135: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 80% | 0.40 | 21% | 79% | 33,023 | 12 | Dominated |
| MNH-136: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 80% | 0.89 | 11% | 89% | 41,725 | 21 | Dominated |
| MNH-137: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 80% | 0.69 | 17% | 83% | 40,491 | 17 | Dominated |
| MNH-138: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 80% | 0.67 | 14% | 86% | 40,184 | 17 | Dominated |
| MNH-139: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 80% | 0.89 | 11% | 89% | 42,614 | 21 | Dominated |
| MNH-140: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.97 | 10% | 90% | 43,230 | 22 | Dominated |
| MNH-141: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 80% | 1.11 | 9% | 91% | 44,255 | 25 | Dominated |
| MNH-142: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 80% | 0.74 | 16% | 84% | 41,779 | 18 | Dominated |
| MNH-143: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 80% | 0.32 | 17% | 83% | 30,762 | 10 | Dominated |
| MNH-144: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 80% | 1.04 | 12% | 88% | 47,874 | 22 | Dominated |
| MNH-145: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.97 | 10% | 90% | 43,230 | 22 | Dominated |
| MNH-146: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 80% | 0.32 | 17% | 83% | 27,117 | 12 | Dominated |
| MNH-147: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.18 | 10% | 90% | 49,020 | 24 | Dominated |
| MNH-148: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 80% | 1.08 | 9% | 91% | 45,660 | 24 | Dominated |
| MNH-149: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 80% | 0.91 | 10% | 90% | 43,441 | 21 | Dominated |
| MNH-150: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 80% | 0.95 | 10% | 90% | 44,044 | 22 | Dominated |
| MNH-151: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 80% | 0.93 | 10% | 90% | 43,747 | 21 | Dominated |
| MNH-152: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 80% | 1.24 | 10% | 90% | 50,920 | 24 | Dominated |
| MNH-153: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 80% | 1.46 | 9% | 91% | 53,349 | 27 | Dominated |
| MNH-154: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.54 | 13% | 87% | 29,551 | 18 | Dominated |
| MNH-155: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.17 | 10% | 90% | 48,353 | 24 | Dominated |
| MNH-156: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 80% | 1.46 | 9% | 91% | 53,349 | 27 | Dominated |
| MNH-157: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 80% | 1.33 | 9% | 91% | 51,734 | 26 | Dominated |
| MNH-158: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 80% | 1.29 | 10% | 90% | 51,131 | 25 | Dominated |
| MNH-159: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 80% | 1.55 | 8% | 92% | 54,163 | 29 | Dominated |
| MNH-160: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 80% | 1.51 | 9% | 91% | 53,560 | 28 | Dominated |
| MNH-161: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.53 | 9% | 91% | 53,866 | 28 | Dominated |
| MNH-162: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.62 | 8% | 92% | 54,623 | 30 | Dominated |
| MNH-163: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 80% | 1.60 | 8% | 92% | 54,374 | 29 | Dominated |
| MNH-164: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 80% | 1.67 | 8% | 92% | 54,834 | 30 | Dominated |
| MNH-165: Community newborn care package + Tetanus Toxoid + SMNC | 80% | 0.54 | 14% | 86% | 32,258 | 17 | Dominated |
| MNH-166: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.54 | 12% | 88% | 33,196 | 16 | Dominated |
| MNH-167: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 80% | 0.55 | 13% | 87% | 35,903 | 15 | Dominated |
| MNH-168: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.59 | 13% | 87% | 31,999 | 19 | Dominated |
| MNH-169: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.60 | 12% | 88% | 35,643 | 17 | Dominated |
| MNH-170: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 80% | 0.79 | 9% | 91% | 35,045 | 22 | Dominated |
| MNH-171: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.79 | 9% | 91% | 38,690 | 20 | Dominated |
| MNH-172: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 80% | 0.79 | 10% | 90% | 37,752 | 21 | Dominated |
| MNH-173: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.79 | 9% | 91% | 38,690 | 20 | Dominated |
| MNH-174: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 80% | 0.79 | 10% | 90% | 41,397 | 19 | Dominated |
| MNH-175: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 80% | 0.65 | 12% | 88% | 39,639 | 16 | Dominated |
| MNH-176: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 80% | 0.95 | 9% | 91% | 42,685 | 22 | Dominated |
| MNH-177: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 80% | 0.75 | 11% | 89% | 40,452 | 18 | Dominated |
| MNH-178: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 80% | 0.70 | 11% | 89% | 39,850 | 18 | Dominated |
| MNH-179: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 80% | 0.80 | 10% | 90% | 40,664 | 20 | Dominated |
| MNH-180: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.36 | 8% | 92% | 51,399 | 27 | Dominated |
| MNH-181: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.37 | 9% | 91% | 52,066 | 26 | Dominated |
| MNH-182: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 80% | 1.44 | 8% | 92% | 52,527 | 27 | Dominated |
| MNH-183: Community newborn care package | 95% | 0.18 | 25% | 75% | 20,429 | 9 | Dominated |
| MNH-184: Support for breastfeeding mothers | 95% | 0.19 | 23% | 77% | 17,323 | 11 | Dominated |
| MNH-185: Pre-eclampsia screening | 95% | 0.19 | 20% | 80% | 1,897 | 99 | Dominated |
| MNH-186: Tetanus toxoid | 95% | 0.19 | 19% | 81% | 8,865 | 22 | Dominated |
| MNH-187: Screening & treatment of asymptomatic bacteriuria | 95% | 0.12 | 33% | 67% | 983 | 117 | Dominated |
| MNH-188: Screening & treatment of syphilis | 95% | 0.12 | 32% | 68% | 813 | 146 | Dominated |
| MNH-189: Normal delivery by a skilled attendant | 95% | 0.33 | 17% | 83% | 7,996 | 42 | Dominated |
| MNH-190: Community-based case management for neonatal pneumonia | 95% | 0.00 | 52% | 48% | 4,207 | 1 | 1 |
| MNH-191: Normal delivery by a skilled attendant + Tetanus Toxoid | 95% | 0.50 | 12% | 88% | 12,047 | 41 | Dominated |
| MNH-192: Management of maternal sepsis | 95% | 0.22 | 2% | 98% | 1,705 | 128 | Dominated |
| MNH-193: Management of severe neonatal asphyxia | 95% | 0.10 | 57% | 43% | 253 | 387 | Dominated |
| MNH-194: Management of serious newborn infections | 95% | 0.40 | 14% | 86% | 5,263 | 77 | Dominated |
| MNH-195: Management of very low birth weight babies | 95% | 0.12 | 47% | 53% | 1,894 | 63 | Dominated |
| MNH-196: Manangement of neonatal jaundice | 95% | 0.10 | 58% | 42% | 77 | 1,235 | Dominated |
| MNH-197: Tetanus toxoid + Pre-eclampsia screening | 95% | 0.27 | 14% | 86% | 10,778 | 25 | Dominated |
| MNH-198: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 95% | 0.28 | 17% | 83% | 11,772 | 24 | Dominated |
| MNH-199: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 95% | 0.29 | 19% | 81% | 12,564 | 23 | Dominated |
| MNH-200: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 95% | 0.53 | 14% | 86% | 14,662 | 36 | Dominated |
| MNH-201: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 95% | 0.51 | 14% | 86% | 15,262 | 33 | Dominated |
| MNH-202: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 95% | 0.97 | 7% | 93% | 15,664 | 62 | Dominated |
| MNH-203: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 95% | 0.59 | 13% | 87% | 14,913 | 39 | Dominated |
| MNH-204: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 95% | 0.61 | 11% | 89% | 12,660 | 48 | Dominated |
| MNH-205: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 95% | 0.83 | 9% | 91% | 14,932 | 56 | Dominated |
| MNH-206: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 95% | 0.62 | 10% | 90% | 14,110 | 44 | Dominated |
| MNH-207: Management of vLBW + Management of serious newborn infections | 95% | 0.47 | 13% | 87% | 7,171 | 66 | Dominated |
| MNH-208: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 95% | 0.51 | 12% | 88% | 7,426 | 69 | Dominated |
| MNH-209: Emergency neonatal care | 95% | 0.56 | 12% | 88% | 9,131 | 61 | Dominated |
| MNH-210: ENC + Management of maternal sepsis | 95% | 0.80 | 8% | 92% | 9,209 | 87 | Dominated |
| MNH-211: Community newborn care package + Community-based pneumonia | 95% | 0.17 | 19% | 81% | 24,758 | 7 | 8 |
| MNH-212: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 95% | 0.61 | 15% | 85% | 15,601 | 39 | Dominated |
| MNH-213: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 95% | 0.67 | 13% | 87% | 17,130 | 39 | Dominated |
| MNH-214: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 95% | 0.73 | 12% | 88% | 16,567 | 44 | Dominated |
| MNH-215: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 95% | 0.97 | 11% | 89% | 20,000 | 48 | Dominated |
| MNH-216: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 95% | 0.82 | 11% | 89% | 17,114 | 48 | Dominated |
| MNH-217: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 95% | 1.10 | 9% | 91% | 20,338 | 54 | Dominated |
| MNH-218: Community newborn care package + Tetanus Toxoid | 95% | 0.37 | 22% | 78% | 29,295 | 13 | Dominated |
| MNH-219: Community-based pneumonia + Tetanus Toxoid | 95% | 0.20 | 20% | 80% | 13,073 | 15 | Dominated |
| MNH-220: Community-based pneumonia + ANC | 95% | 0.30 | 19% | 81% | 16,771 | 18 | Dominated |
| MNH-221: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 95% | 0.36 | 19% | 81% | 33,623 | 11 | 22 |
| MNH-222: Support for breastfeeding mothers + Tetanus toxoid | 95% | 0.38 | 21% | 79% | 26,189 | 14 | Dominated |
| MNH-223: Community newborn care package + ANC | 95% | 0.47 | 21% | 79% | 32,993 | 14 | Dominated |
| MNH-224: Community newborn care package + ANC + Community-based pneumonia | 95% | 0.46 | 19% | 81% | 37,321 | 12 | 27 |
| MNH-225: Community newborn care package + ANC + Community-based pneumonia + SMNC | 95% | 0.82 | 18% | 82% | 46,189 | 18 | 40 |
| MNH-226: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 95% | 0.58 | 25% | 75% | 39,215 | 15 | Dominated |
| MNH-227: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 95% | 1.18 | 13% | 87% | 49,549 | 24 | Dominated |
| MNH-228: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.94 | 21% | 79% | 48,083 | 20 | Dominated |
| MNH-229: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 95% | 0.89 | 17% | 83% | 47,719 | 19 | 42 |
| MNH-230: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 95% | 1.22 | 13% | 87% | 50,604 | 24 | Dominated |
| MNH-231: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.36 | 11% | 89% | 51,336 | 26 | Dominated |
| MNH-232: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 95% | 1.53 | 10% | 90% | 52,553 | 29 | Dominated |
| MNH-233: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 95% | 1.00 | 20% | 80% | 49,612 | 20 | Dominated |
| MNH-234: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 95% | 0.45 | 18% | 82% | 36,529 | 12 | Dominated |
| MNH-235: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 95% | 1.44 | 15% | 85% | 56,850 | 25 | Dominated |
| MNH-236: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.36 | 11% | 89% | 51,336 | 26 | Dominated |
| MNH-237: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 95% | 0.46 | 20% | 80% | 32,201 | 14 | Dominated |
| MNH-238: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.61 | 13% | 87% | 58,211 | 28 | Dominated |
| MNH-239: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 95% | 1.49 | 11% | 89% | 54,221 | 27 | Dominated |
| MNH-240: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 95% | 1.21 | 12% | 88% | 51,587 | 23 | Dominated |
| MNH-241: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 95% | 1.27 | 12% | 88% | 52,302 | 24 | Dominated |
| MNH-242: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 95% | 1.27 | 12% | 88% | 51,949 | 24 | Dominated |
| MNH-243: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 95% | 1.71 | 12% | 88% | 60,467 | 28 | 73 |
| MNH-244: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 95% | 2.04 | 11% | 89% | 63,352 | 32 | 117 |
| MNH-245: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.71 | 17% | 83% | 35,092 | 20 | Dominated |
| MNH-246: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.60 | 12% | 88% | 57,419 | 28 | Dominated |
| MNH-247: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 95% | 2.04 | 11% | 89% | 63,352 | 32 | Dominated |
| MNH-248: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 95% | 1.83 | 12% | 88% | 61,434 | 30 | Dominated |
| MNH-249: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 95% | 1.76 | 12% | 88% | 60,718 | 29 | Dominated |
| MNH-250: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 95% | 2.16 | 10% | 90% | 64,319 | 34 | 125 |
| MNH-251: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 95% | 2.10 | 11% | 89% | 63,603 | 33 | Dominated |
| MNH-252: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.16 | 11% | 89% | 63,965 | 34 | Dominated |
| MNH-253: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.26 | 10% | 90% | 64,865 | 35 | 178 |
| MNH-254: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 95% | 2.22 | 10% | 90% | 64,569 | 34 | Dominated |
| MNH-255: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 95% | 2.32 | 10% | 90% | 65,116 | 36 | 223 |
| MNH-256: Community newborn care package + Tetanus Toxoid + SMNC | 95% | 0.72 | 18% | 82% | 38,307 | 19 | Dominated |
| MNH-257: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.70 | 15% | 85% | 39,420 | 18 | Dominated |
| MNH-258: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 95% | 0.71 | 17% | 83% | 42,635 | 17 | Dominated |
| MNH-259: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.80 | 16% | 84% | 37,998 | 21 | Dominated |
| MNH-260: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.79 | 15% | 85% | 42,327 | 19 | Dominated |
| MNH-261: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 95% | 1.06 | 12% | 88% | 41,616 | 25 | Dominated |
| MNH-262: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 1.05 | 11% | 89% | 45,944 | 23 | Dominated |
| MNH-263: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 95% | 1.07 | 13% | 87% | 44,831 | 24 | Dominated |
| MNH-264: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 1.05 | 11% | 89% | 45,944 | 23 | Dominated |
| MNH-265: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 95% | 1.06 | 12% | 88% | 49,159 | 22 | Dominated |
| MNH-266: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 95% | 0.86 | 15% | 85% | 47,071 | 18 | Dominated |
| MNH-267: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 95% | 1.33 | 10% | 90% | 50,688 | 26 | Dominated |
| MNH-268: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 95% | 0.98 | 13% | 87% | 48,037 | 20 | Dominated |
| MNH-269: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 95% | 0.92 | 14% | 86% | 47,322 | 19 | Dominated |
| MNH-270: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 95% | 1.04 | 12% | 88% | 48,288 | 22 | Dominated |
| MNH-271: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.86 | 10% | 90% | 61,037 | 30 | Dominated |
| MNH-272: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.87 | 11% | 89% | 61,829 | 30 | Dominated |
| MNH-273: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 95% | 1.97 | 10% | 90% | 62,375 | 32 | Dominated |
| MNH-274: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.28 | 17% | 83% | 50,968 | 25 | Dominated |
| MNH-275: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.83 | 21% | 79% | 44,529 | 19 | Dominated |
| MNH-276: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.17 | 16% | 84% | 47,414 | 25 | Dominated |
| MNH-277: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term + Treatment of severe PEE | 95% | 1.34 | 16% | 84% | 52,497 | 26 | Dominated |
| MNH-278: Community newborn care package + ANC + Community-based pneumonia + SMNC + ENC + Steroids pre-term + Treatment of severe PEE | 95% | 1.78 | 12% | 88% | 59,735 | 30 | Dominated |